Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

Investors have long asked the FDA to share its reasons for rejecting drugs, arguing that companies can use the agency’s silence on the matter to mislead the market.

The federal judge reignited the legal standoff over President Trump’s efforts to deny citizenship to children born to ...

A voluntary recall has been issued for select Ritz Peanut Butter Cracker Sandwiches that may be incorrectly labeled and cause ...

The agency disclosed a tranche of more than 200 complete response letters from the past five years, but only those involving ...

From offering financial advice to chair massages, Montgomery County residents are finding ways to support local laid-off ...

The FDA announced a voluntary recall of four sizes of Ritz Peanut Butter Cracker Sandwiches due to a serious labeling issue.

Although 40 states have legalized medical marijuana, the federal government still lists it as a controlled substance.

FDA researchers report that the upper end of reported consumer use (~400mg of daily CBD intake) of cannabidiol (CBD) may ...

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on ...

The FDA published more than 200 letters that it sent to companies when it rejected their medicines, but the letters came with a caveat.